Jagsonpal Pharmaceuticals Share Price
Know More₹414.65-3.05 (-0.73%)
6-Sep-2024₹413.80-3.50 (-0.84%)
6-Sep-2024BSE : 507789
NSE : JAGSNPHARM
Sector : Health care
ISIN Code : INE048B01027
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 06-Sep-2024
| Market Cap (₹ Cr) | 1,097 |
Traded Value (₹ Cr) | 0.33 |
Volume (Shares) | 7,982 |
Face Value (₹) | 5 |
52-Week High (₹) | 475.00 |
52-Week High Date | 12-Sep-2023 |
52-Week Low (₹) | 270.05 |
52-Week Low Date | 14-Mar-2024 |
All Time High (₹) | 513.90 |
All Time High Date | 31-Jul-2023 |
All Time Low (₹) | 1.38 |
All Time Low Date | 18-Oct-1991 |
Jagsonpal Pharmaceuticals Ltd
Market News
Jagsonpal Pharma Announcement
Jagsonpal Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,095 |
| EPS - TTM (₹) [S] | 8.61 |
| P/E Ratio (X) [S] | 48.06 |
| Face Value (₹) | 5 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 06-Sep-2024 |
| Dividend Yield (%) | 1.21 |
| Book Value Share (₹) [S] | 70.84 |
| P/B Ratio (₹) [S] | 5.84 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 100 | 0.03 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 409.00 423.75 |
| Week Low/High (₹) | 396.05 452.00 |
| Month Low/High (₹) | 349.75 452.00 |
| Year Low/High (₹) | 273.60 475.00 |
| All time Low/High (₹) | 1.38 515.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 0.58% | 0.63% | -1.43 | -1.52% |
| 1 Month | 14.29% | 14.52% | 3.30 | 3.58% |
| 3 Month | 26.52% | 26.00% | 8.14 | 8.90% |
| 6 Month | 34.02% | 34.31% | 9.58 | 10.58% |
| 1 Year | -1.09% | -1.26% | 23.23 | 26.73% |
| 3 Year | 192.33% | 192.33% | 39.26 | 43.01% |
Company Info
Company Information
Managing Director : Manish Gupta
Chairman & Non Executive Dir. : Harsha Raghavan
Independent Director : Debasis Bikash Nandy
Independent Director : Radhika Dudhat
Independent Director : Pallavi Dinodia
Non Executive Director : Prithipal Singh Kochhar
Company Sec. & Compli. Officer : Abhishek Joshi
Registered Office: T-210 J, Shahpur Jat,New Delhi,New Delhi-110049 Ph: 91-011-46181100/46109900
FAQs about Jagsonpal Pharmaceuticals Ltd
1. What's the Jagsonpal Pharmaceuticals Ltd share price today?
Jagsonpal Pharmaceuticals Ltd share price was Rs 414.65 at close on 6th Sep 2024. Jagsonpal Pharmaceuticals Ltd share price was down by 0.73% from the previous closing price of Rs 417.70. Jagsonpal Pharmaceuticals Ltd share price trend:
- Last 1 Month: Jagsonpal Pharmaceuticals Ltd share price moved up by 14.29% on BSE
- Last 3 Months: Jagsonpal Pharmaceuticals Ltd share price moved up by 26.52% on BSE
- Last 12 Months: Jagsonpal Pharmaceuticals Ltd share price moved down by 1.09% on BSE
- Last 3 Years: Jagsonpal Pharmaceuticals Ltd price moved up by 192.33% on BSE
2. How can I quickly analyse the performance of the Jagsonpal Pharmaceuticals Ltd stock?
The performance of the Jagsonpal Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 48.06
- Price to book value ratio is 5.84
- Dividend yield of 1.21
- The EPS (trailing 12 months) of the Jagsonpal Pharmaceuticals Ltd stock is Rs 8.61
3. What is the market cap of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd has a market capitalisation of Rs 1,097 crore.
4. What is Jagsonpal Pharmaceuticals Ltd's 52-week high/low share price?
The Jagsonpal Pharmaceuticals Ltd’s 52-week high share price is Rs 475.00 and 52-week low share price is Rs 270.05.
5. Is the Jagsonpal Pharmaceuticals Ltd profitable?
On a consolidated basis, Jagsonpal Pharmaceuticals Ltd reported a profit of Rs 5.33 crore on a total income of Rs 62.88 crore for the quarter ended 2024. For the year ended Jun 2024, Jagsonpal Pharmaceuticals Ltd had posted a profit of Rs 5.33 crore on a total income of Rs 62.88 crore.
6. Which are Jagsonpal Pharmaceuticals Ltd’s peers in the Health care sector?
Jagsonpal Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Bliss GVS Pharma, Nectar Lifesci., Shree Ganesh Rem, Jagsonpal Pharma, Anuh Pharma, Bajaj Healthcare, Bharat Parenter..
7. Who owns how much in Jagsonpal Pharmaceuticals Ltd?
Key changes to the Jagsonpal Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Jagsonpal Pharmaceuticals Ltd has gone down to 68.04 per cent as of Jun 2024 from 68.72 per cent as of Sep 2023.
